money

Peter Oborne opens a media can of worms

Just because we are encouraged to avert our gaze from the dependency of the media on advertising does not mean that interference by advertisers will cease. The relationship was poisoning the integrity of our media and journalists long before the Oborne revelations and it will continue doing so long after – or until we come up with a completely different model of media funding.
The post Peter Oborne opens a media can of worms appeared first on BSNEWS.

Princes of the Yen: Central Banks and the Transformation of the Economy

Princes of the Yen offers a disturbing new look at Japan's post-war economy and the key factors that shaped it. It gives special emphasis to the 1980s and 1990s when Japan's economy experienced vast swings in activity. According to the author, the most recent upheaval in the Japanese economy is the result of the policies of a central bank less concerned with stimulating the economy than with its own turf battles and its ideological agenda to change Japan's economic structure.

Why Public Banks Outperform Private Banks: Unfair Competition or a Better Mousetrap?

Public banks in North Dakota, Germany and Switzerland have been shown to outperform their private counterparts. Under the TPP and TTIP, however, publicly-owned banks on both sides of the oceans might wind up getting sued for unfair competition because they have advantages not available to private banks.
The post Why Public Banks Outperform Private Banks: Unfair Competition or a Better Mousetrap? appeared first on BSNEWS.

8 Reasons Monsanto is Defeating GMO Labeling Initiatives

The moneyed corporations running the GMO show certainly don’t make it easy. Now that they have won not one, but four different GMO labeling battles, what makes anyone think we can win against Monsanto, Dow, Syngenta, Bayer, Cargill, and the GMA, just to name a few Round-Up-Ready giants? Though a difficult food war to overcome, we do have the power and collective voice to win – but we must all know what we’re up against.
“If you are going through hell, keep going.”
~ Winston Churchill

Big Pharma ‘Repatenting’ Raises Prices of Top Drugs By More than 6 Times

What happens when mega pharmaceutical companies get their new grip around one of the oldest asthma medications that many rely on for daily use? Based on historical data, it appears that one of the first action items is to exponentially increase the price of the same medication without any actual advancements of any kind. It’s a process that is involved with ‘repatenting.’